Digital Diabetes Management is expected to grow significantly in the forecasted period with the rising prevalence of diabetes and the growing adoption of the digital platform for diabetes. The rising incidence of type I and type II diabetes combined with high obese population is propelling the market for digital diabetes market.
This growth is primarily driven by Growing Demand for Technologically Advanced Solutions Such As Closed-Loop Systems, High Adoption of Connected Diabetes Management Devices and Apps, Rising Awareness on Self-Diabetes Management, Favorable Reimbursement Policies and Increased Acceptance of Digital Diabetes Solutions from Payers.
Globally, a noticeable market trend is evident Growing Demand for Hybrid Closed-Loop Systems/Artificial Pancreas Device Systems
. Major Players, such as Roche Diagnostics (Switzerland), Medtronic (Ireland), Glooko Inc. (United States), B. Braun (Germany), Dexcom (United States), Abbott Laboratories (United States), Insulet Corporation (United States), Tandem Diabetes Care (United States), Ascensia Diabetes Care (Switzerland) and Lifescan (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
In 2018, Medtronic plc acquired Neutrino Health Ltd. (Israel). This acquisition strengthened Metronic’s CGM and industry-leading hybrid closed-loop systems portfolio in the digital diabetes management market. and In 2018, Roche Diagnostics signed a partnership with Wellthy Therapeutics Private Limited (India) that offers an artificial intelligence-based digital diabetes coaching solution for users of the Accu-Chek Active system.
- Growing Demand for Technologically Advanced Solutions Such As Closed-Loop Systems
- High Adoption of Connected Diabetes Management Devices and Apps
- Rising Awareness on Self-Diabetes Management
- Favorable Reimbursement Policies
- Increased Acceptance of Digital Diabetes Solutions from Payers
- Growing Demand for Hybrid Closed-Loop Systems/Artificial Pancreas Device Systems
- Increasing Demand for Flash Glucose Monitoring (FGM) Systems
- Lack of Awareness toward Healthcare-Associated Applications
- Cost Sensitivity and Limited Infrastructure For Management
Increasing Demand for Remote Monitoring & Penetration of Smartphone-Connected Handheld Devices, Rising Global Adoption of Remote Online Coaching Services among Diabetes Patients and Government Initiatives to Promote Digital Health in the Region
Low Penetration in Developing Economies and Lack of Data Security
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Digital Diabetes Management Study Sheds Light on
The Digital Diabetes Management Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Digital Diabetes Management industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Digital Diabetes Management industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.
Frequently Asked Questions (FAQ):1. What is the growth rate predicted for the Global Digital Diabetes Management Market?
The Digital Diabetes Management market is expected to see a CAGR of % during projected year 2020 to 2026.
2. Who are the top performing companies in Digital Diabetes Management Market?
Top performing companies in the Global Digital Diabetes Management market are Roche Diagnostics (Switzerland), Medtronic (Ireland), Glooko Inc. (United States), B. Braun (Germany), Dexcom (United States), Abbott Laboratories (United States), Insulet Corporation (United States), Tandem Diabetes Care (United States), Ascensia Diabetes Care (Switzerland) and Lifescan (United States), to name a few.
3. Which region dominated the worldwide market for Digital Diabetes Management in 2020?
is dominating the Digital Diabetes Management Market.